BackgroundIn recent years, a number of investigations have evaluated the effect of cannabis use on the risk of presenting ultra-high risk for psychosis (UHR) status as well as its influences on transition rate, suggesting a dose-dependent interaction. On the other hand, the association between cocaine (snorted or smoked) - an increasing health issue in several countries worldwide - and the UHR state was not appropriately examined. Also, exposure to other psychotomimetic drugs, as amphetamines and lysergic acid diethylamide (LSD), has not been investigated yet. We sought to examine differences in the prevalence of drug use between UHR subjects and epidemiologic controls (EC).MethodsOver 2500 individuals from the city of São Paulo (Brazil), aged between 18 and 30 years old, were screened with the Prodromal Questionnaire. Subjects with scores higher than 18 points in the positive subscale were invited to be thoroughly assessed with the application of SIPS (Structured Interview for Psychosis-Risk Syndromes). Drug use (lifetime use, age of first use and more intense use) was assessed using South Westminster scale.Results100 individuals presented UHR state; other 110 were enrolled as EC. A subsample of 50 UHR subjects and 82 HC with data on drugs consumption were evaluated herein. UHR subjects history of lifetime drug use was: 19 (38%) cannabis; 5 (10%) snorted cocaine; 1 (2%) crack; 1 (2%) amphetamine; 2 (6.9%) LSD. EC history of lifetime drug use was: 20 (24.4%) cannabis; 6 (7.3%) snorted cocaine; 0 crack; 2 (2.4%) amphetamine; 1 (1.2%) LSD. No differences were observed for snorted cocaine (p=0.589), crack (p=0.379), amphetamine (p=1.0), or LSD (P=0.167). At a trend level, cannabis lifetime use (p=0.096) was more prevalent in the UHR group. Additional analyses showed that UHR subjects initiate cannabis use at earlier age than EC (p=0.006). In this group, 20% of subjects had used cannabis prior to 15 years of age, in comparison to 3.6% in the EC group.DiscussionOur results reinforce the view that cannabis use is linked to psychosis risk and that subjects at early age of exposure are at greatest risk. Nonetheless, studies with larger number of participants are warranted to confirm our findings, particularly on the lack of association between less frequently consumed drugs and the UHR for psychosis state.
Background: Childhood maltreatment is a known risk factor for the development of mental disorders, such as psychotic symptoms. An extensive body of literature about childhood maltreatment and mental health has been developed in wealthy countries, but information about this connection is lacking in developing countries. Aims: To explore a possible relationship between childhood maltreatment and ultra-high risk of psychosis in a non-help-seeking population in a low- and middle-income country. Methods: A household survey was conducted in Sao Paulo, Brazil, involving over 2,500 individuals aged 18–30 years who were randomly selected from the general population. The participants underwent screening with the Prodromal Questionnaire. Ultra-high risk status was assessed using the Structured Interview for Prodromal Syndromes, and childhood maltreatment was assessed using the Childhood Trauma Questionnaire. The final sample comprised 87 ultra-high risk individuals and 115 controls. Results: Childhood maltreatment was significantly more present among ultra-high risk individuals. In ultra-high risk individuals, physical and emotional neglect were inversely related to grandiosity symptoms, physical abuse was related to perceptual abnormalities and physical neglect was related to disorganized speech and thought. Conclusion: This is the first study to investigate the relationship between childhood maltreatment and ultra-high risk status and psychopathological features in a large Latin American sample. Further studies in this field are necessary to better understand the specific influence of various early life adversities on psychosis risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.